on June 14, 2026
If you've ever struggled to explain your PCOS diagnosis to a doctor, a partner, or even yourself, you're not alone. For decades, the name "Polycystic Ovary Syndrome" has been quietly misleading millions of people about the true nature of their condition.
That's finally changing.
In May 2026, an international team of researchers, clinicians and patient advocates published a landmark consensus in The Lancet: the condition we've known as PCOS now has a new name. It's called Polyendocrine Metabolic Ovarian Syndrome, or PMOS.
And while a name change might sound like a small thing, this one carries real weight.
Why "Polycystic Ovary Syndrome" Was Always a Bit of a Misnomer
Here's something that surprises a lot of people: many individuals diagnosed with PCOS don't actually have ovarian cysts. What shows up on ultrasound are immature follicles, not true cysts. The name has been misleading from the start.
More importantly, the old name completely missed some of the most significant features of the condition. Insulin resistance. Metabolic changes. Skin symptoms. Mood and mental health impacts. None of those appear anywhere in "Polycystic Ovary Syndrome."
The result? A condition that affects an estimated 1 in 8 women worldwide, around 170 million people, was routinely framed as primarily a fertility or ovarian issue. Research suggests that up to 70% of people with the condition experience diagnostic delays, often because their symptoms didn't fit the narrow picture the name painted.
What the New Name Actually Tells Us
The new name, Polyendocrine Metabolic Ovarian Syndrome, was chosen deliberately. Each word does real work:
- Polyendocrine recognises that this is a condition involving multiple hormonal systems, including insulin, androgens and neuroendocrine pathways, not just one
- Metabolic acknowledges the links with insulin resistance, blood sugar regulation, cardiovascular health and weight
- Ovarian confirms that the ovaries remain part of the picture, without making them the whole story
Together, the name reflects what people living with this condition have known for years: this is a complex, whole-body condition, not simply a reproductive one.
This Change Was a Long Time Coming
The renaming didn't happen overnight. It followed 14 years of global research, consultation and advocacy, described by researchers as "an unprecedented, rigorous, multistep global consensus process." Fifty-six international academic, clinical and patient organisations were involved. More than 22,000 health professionals and people living with the condition participated in surveys and workshops across multiple world regions.
The result? 85.6% of patients and 76.1% of health professionals agreed with the change.
And there's an Australian connection worth celebrating here. The process was led by Professor Helena Teede of Monash University, one of the world's foremost researchers in women's hormonal health. This is world-leading science happening right here in our own backyard.
Does Anything Change for You Right Now?
The short answer is: not immediately.
The diagnostic criteria for the condition are not changing. If you already have a PCOS diagnosis, your symptoms, testing processes and treatment approaches remain the same for now. A three-year transition plan is underway, with the new terminology expected to be formally incorporated into the International Guideline, used across 195 countries, when it is updated in 2028.
In the meantime, you'll see both names used side by side as healthcare providers, researchers and organisations adapt.
It's also worth acknowledging that not everyone in the community is celebrating. Some long-time advocates have raised genuine concerns about losing the visibility and community that the PCOS name has built over decades. That's a fair and important point, and one the researchers have acknowledged as part of the transition.
Why the Language We Use About Our Health Matters
Words shape how we understand ourselves and how we're understood by others, including our doctors.
When a condition is named after one feature (ovarian cysts) that many people don't even have, it creates confusion, delays and a sense that your experience doesn't quite fit. It can make it harder to advocate for yourself in a medical setting. It can make it harder to get a referral to the right specialist. It can make it harder to feel seen.
A name that more accurately reflects the hormonal, metabolic and psychological dimensions of this condition is a step toward better care, earlier diagnosis and more holistic treatment that addresses the full picture, not just the reproductive piece.
To conclude
PCOS becoming PMOS is more than a semantic update. It's a recognition, backed by global science and patient voices, that this condition has always been bigger and more complex than its old name suggested.
For the millions of people living with it, that recognition is long overdue.
As the transition unfolds over the coming years, the hope is that more people will receive earlier, more accurate diagnoses and care that truly reflects their experience.
Want to understand the full picture of PCOS/PMOS? Read our guide: Understanding PCOS
